Evaluation of the therapeutic safety of beta-blockers in acute heart failure in hospital emergency
DOI:
https://doi.org/10.33448/rsd-v12i13.44120Keywords:
Beta-blockers; Acute heart failure; Emergency.Abstract
Beta-blockers are essential drugs for the treatment of Chronic Heart Failure (HF), and their use for heart rate (HR) control in acute HF was not properly standardized due to the association with serious adverse effects. However, recent studies suggest that the use of these drugs can reduce morbidity and mortality rates generated in acute HF. Thus, the objective of this study is to evaluate the safety of beta-blockers in patients hospitalized for acute heart failure in the hospital emergency department. This is an integrative literature review carried out between January and June 2023 based on the PubMed and BVS databases. At the end of the selection, 13 studies were analyzed, including randomized clinical trials, prospective, retrospective and ambispective studies, case reports and systematic review, in which the clinical safety of various beta-blockers was demonstrated with a significant reduction in morbidity and mortality rates and low rates of associated adverse effects in patients with acute HF and good peripheral perfusion, but its use is still proscribed in patients with low output profiles. Therefore, beta-blockers, especially caverdilol and landiolol, are recommended for controlling HR in patients with acute HF and good perfusion, as they reduce morbidity and mortality rates and readmissions resulting from these conditions.
References
Alexsander, R., de Las Casas Bessa, L., Dias Silveira, A. V., Gualberto Souza, I., Silveira Ferreira, G. F., Pacheco Souza, G., & Schimdt França, D. (2022). Análise Epidemiológica por Insuficiência Cardíaca no Brasil. Brazilian Medical Students, 6(9). https://doi.org/10.53843/bms.v6i9.224
Arruda, V. L., Machado, L. M. G., Lima, J. C., & Silva, P. R. S. (2022). Trends in mortality from heart failure in Brazil: 1998 to 2019. Tendência da mortalidade por insuficiência cardíaca no Brasil: 1998 a 2019. Revista brasileira de epidemiologia = Brazilian journal of epidemiology, 25, E220021. https://doi.org/10.1590/1980-549720220021.2
Bortolotto, L. A., & Consolin-Colombo, F. M. (2009). Betabloqueadores adrenérgicos. Revista Brasileira de Hipertensão, 16(4), 215-220. http://departamentos.cardiol.br/dha/revista/16-4/06-betabloqueadores.pdf
Boully, C., & Hanon, O. (2015). Insuffisance cardiaque et pathologies associées [Heart failure and comorbidities]. Geriatrie et psychologie neuropsychiatrie du vieillissement, 13 Suppl 1, 13–22. https://doi.org/10.1684/pnv.2015.0544
Butler, J., Young, J. B., Abraham, W. T., Bourge, R. C., Adams, K. F., Jr, Clare, R., O'Connor, C., & ESCAPE Investigators (2006). Beta-blocker use and outcomes among hospitalized heart failure patients. Journal of the American College of Cardiology, 47(12), 2462–2469. https://doi.org/10.1016/j.jacc.2006.03.030
Cho, M. S., Kim, M. S., Lee, S. E., Choi, H. I., Lee, J. B., Cho, H. J., Lee, H. Y., Choi, J. O., Jeon, E. S., Hwang, K. K., Chae, S. C., Baek, S. H., Kang, S. M., Choi, D. J., Yoo, B. S., Ahn, Y., Kim, K. H., Park, H. Y., Cho, M. C., Oh, B. H., & Kim, J. J. (2018). Outcomes After Predischarge Initiation of β-Blocker in Patients Hospitalized for Severe Decompensated Heart Failure Requiring Inotropic Therapy. The Canadian journal of cardiology, 34(9), 1145–1152. https://doi.org/10.1016/j.cjca.2018.05.005
Dabrowski, W., Siwicka-Gieroba, D., Piasek, E., Schlegel, T. T., & Jaroszynski, A. (2020). Successful Combination of Landiolol and Levosimendan in Patients with Decompensated Heart Failure. International heart journal, 61(2), 384–389. https://doi.org/10.1536/ihj.19-420
Ditali, V., Garatti, L., Morici, N., Villanova, L., Colombo, C., Oliva, F., & Sacco, A. (2022). Effect of landiolol in patients with tachyarrhythmias and acute decompensated heart failure (ADHF): a case series. ESC heart failure, 9(1), 766–770. https://doi.org/10.1002/ehf2.13763
Fonarow, G. C., Abraham, W. T., Albert, N. M., Stough, W. G., Gheorghiade, M., Greenberg, B. H., O'Connor, C. M., Sun, J. L., Yancy, C. W., Young, J. B., & OPTIMIZE-HF Investigators and Coordinators (2008). Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure: findings from the OPTIMIZE-HF program. Journal of the American College of Cardiology, 52(3), 190–199. https://doi.org/10.1016/j.jacc.2008.03.048
Ganapathi, S., Jeemon, P., Krishnasankar, R., Kochumoni, R., Vineeth, P., Mohanan Nair, K. K., Valaparambil, A. K., & Harikrishnan, S. (2020). Early and long-term outcomes of decompensated heart failure patients in a tertiary-care centre in India. ESC heart failure, 7(2), 467–473. https://doi.org/10.1002/ehf2.12600
Grewal, D., Partow-Navid, R., Garcia, D., Coney, J., Fraser, G., Stoletniy, L., Sakr, A., Parwani, P., & Abramov, D. (2021). Role of guideline directed medical therapy doses and optimization in patients hospitalized with decompensated systolic heart failure. The American journal of cardiology, 151, 64–69. https://doi.org/10.1016/j.amjcard.2021.04.017
Groenewegen, A., Rutten, F. H., Mosterd, A., & Hoes, A. W. (2020). Epidemiology of heart failure. European journal of heart failure, 22(8), 1342–1356. https://doi.org/10.1002/ejhf.1858
Jondeau, G., Neuder, Y., Eicher, J. C., Jourdain, P., Fauveau, E., Galinier, M., Jegou, A., Bauer, F., Trochu, J. N., Bouzamondo, A., Tanguy, M. L., Lechat, P., & B-CONVINCED Investigators (2009). B-CONVINCED: Beta-blocker CONtinuation Vs. INterruption in patients with Congestive heart failure hospitalizED for a decompensation episode. European heart journal, 30(18), 2186–2192. https://doi.org/10.1093/eurheartj/ehp323
Kiuchi, S., Aikawa, H., Hisatake, S., Kabuki, T., Oka, T., Dobashi, S., Fujii, T., & Ikeda, T. (2017). Efficacy of Intravenous Administration of Landiolol in Patients with acute heart failure and Supraventricular Tachyarrhythmia. Journal of clinical medicine research, 9(5), 426–432. https://doi.org/10.14740/jocmr2954w
Kobayashi, S., Murakami, W., Myoren, T., Tateishi, H., Okuda, S., Doi, M., Nao, T., Wada, Y., Matsuzaki, M., & Yano, M. (2014). A low-dose β1-blocker effectively and safely slows the heart rate in patients with acute decompensated heart failure and rapid atrial fibrillation. Cardiology, 127(2), 105–113. https://doi.org/10.1159/000355312
Khalil, A. C., Sulaiman, K., Mahfoud, Z., Singh, R., Asaad, N., AlHabib, K. F., Alsheikh-Ali, A., Al-Jarallah, M., Bulbanat, B., AlMahmeed, W., Ridha, M., Bazargani, N., Amin, H., Al-Motarreb, A., Faleh, H. A., Elasfar, A., Panduranga, P., Suwaidi, J. A., & GULF-CARE group (2017). Non-withdrawal of beta blockers in acute decompensated chronic and de novo heart failure with reduced ejection fraction in a prospective multicentre study of patients with acute heart failure in the Middle East. BMJ open, 7(7), e014915. https://doi.org/10.1136/bmjopen-2016-014915
Kveiborg, B., Major-Petersen, A., Christiansen, B., & Torp-Pedersen, C. (2007). Carvedilol in the treatment of chronic heart failure: lessons from the Carvedilol Or Metoprolol European Trial. Vascular health and risk management, 3(1), 31–37. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1994038/
Llorens, P., Escoda, R., Miró, Ò., Herrero-Puente, P., Martín-Sánchez, F. J., Jacob, J., Garrido, J. M., Pérez-Durá, M. J., Gil, C., Fuentes, M., Alonso, H., Muller, C., Mebazaa, A., & Representación de los participantes del estudio del grupo de trabajo ICA-SEMES (2015). Características clínicas, terapéuticas y evolutivas de los pacientes con insuficiencia cardiaca aguda atendidos en servicios de urgencias españoles: Registro EAHFE (Epidemiology of Acute Heart Failure in Spanish Emergency Departments) [Characteristics and clinical course of patients with acute heart failure and the therapeutic measures applied in Spanish emergency departments: based on the EAHFE registry (Epidemiology of Acute Heart Failure in Emergency Departments)]. Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias, 27(1), 11–22.
Long, B., Koyfman, A., & Gottlieb, M. (2018). Management of Heart Failure in the Emergency Department Setting: An Evidence-Based Review of the Literature. The Journal of emergency medicine, 55(5), 635–646. https://doi.org/10.1016/j.jemermed.2018.08.002
López-Vilella, R., Laymito Quispe, R. D. P., Donoso-Trenado, V., Sánchez-Lázaro, I., Martínez Dolz, L., & Almenar Bonet, L. (2022). Changes in the Treatment of Decompensated Advanced Heart Failure During Hospitalization and at Discharge. Transplantation proceedings, 54(9), 2497–2499. https://doi.org/10.1016/j.transproceed.2022.10.002
Mangini, S., Pires, P. V., Braga, F. G. M., & Bacal, F. (2013). Insuficiência cardíaca descompensada. Einstein (são Paulo), 11(3), 383–391. https://doi.org/10.1590/S1679-45082013000300022
Miró, Ò., Müller, C., Martín-Sánchez, F. J., Bueno, H., Mebazaa, A., Herrero, P., Jacob, J., Gil, V., Escoda, R., Llorens, P., & ICA-SEMES Research Group (2016). BETAWIN-AHF study: effect of beta-blocker withdrawal during acute decompensation in patients with chronic heart failure. Clinical research in cardiology: official journal of the German Cardiac Society, 105(12), 1021–1029. https://doi.org/10.1007/s00392-016-1014-9
Palin, V., Drozd, M., Garland, E., Malik, A., Straw, S., McGinlay, M., Simms, A., Gatenby, V. K., Sengupta, A., Levelt, E., Witte, K. K., Kearney, M. T., & Cubbon, R. M. (2022). Reduction of heart failure guideline-directed medication during hospitalization: prevalence, risk factors, and outcomes. ESC heart failure, 9(5), 3298–3307. https://doi.org/10.1002/ehf2.14051
Pereira, A. A., Moreira, C. L. V., Fernandes, F. S. B., Cançado, G. G. L., Garcia, I. F., Maia, J. C., Félix, L. R., Camargos, L. S., & Ferreira, G. A. (n.d.). Diagnóstico e abordagem da insuficiência cardíaca agudam no serviço de emergência. Ver Med Minas Gerais, 19(2), 117–127.
Pinheiro T. G., Junior P. S. L. A., de Azevedo M. C. A., Viana E. A. S., Magalhães B. B., Souza L. V., Ferreira B. M. A., Fernandes Y. M., Gusmão F. A. dos S., & Neves E. M. F. (2021). A relação entre o uso de betabloqueadores e a exacerbação da Doença Pulmonar Obstrutiva Crônica: uma revisão integrativa. Revista Eletrônica Acervo Saúde, 13(4), e7248. https://doi.org/10.25248/reas.e7248.2021
Ponikowski, P., & Jankowska, E. A. (2015). Pathogenesis and Clinical Presentation of Acute Heart Failure. Revista Española de Cardiología (English Edition), 68(4), 331–337. https://doi.org/10.1016/j.rec.2015.02.001
Shiga T. (2022). Benefits and safety of landiolol for rapid rate control in patients with atrial tachyarrhythmias and acute decompensated heart failure. European heart journal supplements: journal of the European Society of Cardiology, 24(Suppl D), D11–D21. https://doi.org/10.1093/eurheartjsupp/suac023
Rossi Neto, J. M., Casadei, C., & Finger, M. A. (2020). Insuficiência cardíaca aguda. Rev. Soc. Cardiol. Estado de Säo Paulo, 147–157.
http://dx.doi.org/10.29381/0103-8559/20203002147-57
Sánchez-Marteles, M., Rubio Gracia, J., & Giménez López, I. (2016). Fisiopatología de la insuficiencia cardiaca aguda: un mundo por conocer. Revista Clínica Española, 216(1), 38–46. https://doi.org/10.1016/j.rce.2015.09.010
Santos, M. A. R. C., & Galvão, M. G. A. (2014). A elaboração da pergunta adequada de pesquisa. Resid Pediatr., 4(2), 53-56. https://doi.org/10.25060/residpediatr
Sociedade Brasileira de Cardiologia (2018). Diretriz Brasileira de Insuficiência Cardíaca Crônica e Aguda. Arquivos Brasileiros De Cardiologia, 111(3), 436–539. https://doi.org/10.5935/abc.20180190
Teixeira, M., & Tavares, L. P. (2007). Insuficiência cardíaca aguda – uma revisão. Medicina Interna, 14(3), 157–169. https://revista.spmi.pt/index.php/rpmi/article/view/1565
Yamakage, M., Iwasaki, S., Jeong, S.-W., Satoh, J.-I., & Namiki, A. (2009). Beta-1 selective adrenergic antagonist landiolol and esmolol can be safely used in patients with airway hyperreactivity. Heart & Lung, 38(1), 48–55. https://doi.org/10.1016/j.hrtlng.2008.01.002
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Alysson Lima Nunes; Onildo de Oliveira Bomfim Junior; Carlos José Rodrigues dos Santos Junior; Eurípedes Inácio de Oliveira Neto; Jefte Camilo de Lima Rodrigues; Guilherme Gonçalves Bezerra de Jesus; Italo Rossi Roseno Martins
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
